| # | Holder | Shares | % of Shares Out | Change | Filing Date |
|---|---|---|---|---|---|
| 1 |
Pursglove (Geordan Garrett)
|
350.000k | 3.01% | +350.000k | Apr 15 2026 |
| 2 |
Scotia Capital Inc.
|
283.162k | 2.43% | +24.449k | Mar 31 2026 |
| 3 |
Orca Capital GmbH
|
120.012k | 1.03% | +120.012k | Feb 14 2025 |
| 4 |
Renaissance Technologies LLC
|
93.000k | 0.80% | -14.500k | Mar 31 2026 |
| 5 |
Desjardins Securities Inc.
|
64.487k | 0.55% | -28.893k | Mar 31 2026 |
|
1
Pursglove (Geordan Garrett)
|
3.01%
350.000k
|
|
2
Scotia Capital Inc.
|
2.43%
283.162k
|
|
3
Orca Capital GmbH
|
1.03%
120.012k
|
|
4
Renaissance Technologies LLC
|
0.80%
93.000k
|
|
5
Desjardins Securities Inc.
|
0.55%
64.487k
|
| The largest shareholders show who really holds influence: big institutional owners shape a stock's liquidity, and building or cutting positions can move the price. | |
| The 5 largest shareholders together hold 7.83% of Lixte Biotechnology Holdings Inc, with Pursglove (Geordan Garrett) the biggest at 3.01%, followed by Scotia Capital Inc. (2.43%) and Orca Capital GmbH (1.03%). |
| Short interest shows what share of a stock's freely tradable shares (float) is currently sold short, meaning held by investors betting on falling prices. A high or rising level can be read two ways: it reflects the skepticism of many market participants, but also carries upside potential. Because if the stock rises, short sellers have to buy back, which can push the price up even further. This effect is called a short squeeze. | |
| The short interest in Lixte Biotechnology Holdings Inc has held steady at around 2.2% of the float over the past 12 months. Short sellers' positioning has barely changed in this period. |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


